The first patient was dosed in the SKYBRIDGE study assessing peluntamig with Tecentriq for advanced small cell lung cancer ...

The development of second tumors is influenced by several factors. These include the type and intensity of treatment received ...

About one-sixth of neuroendocrine tumors are classified by pathologists as high grade. Survival rates from high-grade cancer vary with the site of disease, but most patients succumb within a year ...

Increasing Incidence of Neuroendocrine Tumors: Globally rising cases demand effective treatment ... Increasing Number of Clinical Trials: Ongoing trials for novel treatments improve survival rates and ...

Results demonstrated a statistically significant and clinically meaningful improvement in progression-free survival ... heterogeneous tumors that originate from the neuroendocrine cells of the ...